1mtb
From Proteopedia
(Difference between revisions)
Line 2: | Line 2: | ||
<StructureSection load='1mtb' size='340' side='right' caption='[[1mtb]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='1mtb' size='340' side='right' caption='[[1mtb]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[1mtb]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[1mtb]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MTB OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1MTB FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DIQ:2-METHYL-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC+ACID'>DIQ</scene>, <scene name='pdbligand=QNC:QUINOLINE-2-CARBOXYLIC+ACID'>QNC</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DIQ:2-METHYL-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC+ACID'>DIQ</scene>, <scene name='pdbligand=QNC:QUINOLINE-2-CARBOXYLIC+ACID'>QNC</scene></td></tr> | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=HPH:(2S)-2-AMINO-3-PHENYLPROPANE-1,1-DIOL'>HPH</scene>, <scene name='pdbligand=NTB:TERTIARY-BUTYLAMINE'>NTB</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=HPH:(2S)-2-AMINO-3-PHENYLPROPANE-1,1-DIOL'>HPH</scene>, <scene name='pdbligand=NTB:TERTIARY-BUTYLAMINE'>NTB</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1f7a|1f7a]], [[1hxb|1hxb]], [[1mt7|1mt7]], [[1mt8|1mt8]], [[1mt9|1mt9]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1f7a|1f7a]], [[1hxb|1hxb]], [[1mt7|1mt7]], [[1mt8|1mt8]], [[1mt9|1mt9]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1mtb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1mtb OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1mtb RCSB], [http://www.ebi.ac.uk/pdbsum/1mtb PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1mtb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1mtb OCA], [http://pdbe.org/1mtb PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1mtb RCSB], [http://www.ebi.ac.uk/pdbsum/1mtb PDBsum]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
Line 29: | Line 29: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 1mtb" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Line 34: | Line 35: | ||
</StructureSection> | </StructureSection> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
- | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: King, N M]] | [[Category: King, N M]] | ||
[[Category: Nalivaika, E A]] | [[Category: Nalivaika, E A]] |
Revision as of 16:29, 10 September 2015
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy
|